Phase II trial of the association of doxorubicin, 5 FU and cis platinum in hormonally unresponsive metastatic carcinoma of the prostate.

Droz, J P

Phase II trial of the association of doxorubicin, 5 FU and cis platinum in hormonally unresponsive metastatic carcinoma of the prostate. [electronic resource] - Progress in clinical and biological research 1987 - 235-42 p. digital

Publication Type: Journal Article

0361-7742


Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cisplatin--administration & dosage
Doxorubicin--administration & dosage
Drug Evaluation
Fluorouracil--administration & dosage
Humans
Male
Middle Aged
Prostatic Neoplasms--drug therapy